| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | D2A6T4UH9C |
| InChI Key | HKHCSWPSUSWGLI-CABCVRRESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H15N |
| Molecular Weight | 209.29 |
| AlogP | 2.7 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 12.03 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 16.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Monoamine transporter inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 10 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Attention Deficit Disorder with Hyperactivity | 3 | D001289 | ClinicalTrials |
| Smoking Cessation | 2 | D016540 | ClinicalTrials |
| Feeding and Eating Disorders | 2 | D001068 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3301621 |
| DrugBank | DB14841 |
| FDA SRS | D2A6T4UH9C |
| PubChem | 16095349 |
| SureChEMBL | SCHEMBL4187417 |